Calculating qualified non-mutagenic impurity levels: Harmonization of approaches
- 1 November 2021
- journal article
- research article
- Published by Elsevier in Regulatory Toxicology and Pharmacology
- Vol. 126, 105023
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- Harmonized 3Rs-based non-mutagenic impurity qualification study designs developed using the results of an IQ consortium surveyRegulatory Toxicology and Pharmacology, 2021
- Establishing Patient Centric Specifications for Drug Substance and Drug Product ImpuritiesJournal of Pharmaceutical Innovation, 2018
- Advancing internal exposure and physiologically-based toxicokinetic modeling for 21st-century risk assessmentsJournal of Exposure Science & Environmental Epidemiology, 2018
- Management of organic impurities in small molecule medicinal products: Deriving safe limits for use in early developmentRegulatory Toxicology and Pharmacology, 2017